Skip to content

XIENCE XPEDITION 1074225-23Recalls & reported problems

Abbott Vascular Inc. · XIENCE Xpedition SV Everolimus Eluting Coronary Stent System 2.25 mm x 23 mm / Rapid-Exchange · Class 3 · Implant

All models of XIENCE XPEDITION (41)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648162053), received between May 3, 2018 and May 3, 2018 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Stenosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 3, 2018Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2015, THE PATIENT WAS HOSPITALIZED WITH UNSTABLE ANGINA AND UNDERWENT CORONARY INTERVENTION ON (B)(6) 2015. A 2.25 X 23 MM XIENCE XPEDITION STENT WAS IMPLANTED IN THE DISTAL LEFT CIRCUMFLEX ARTERY. ON (B)(6) 2017, THE PATIENT WAS RE-HOSPITALIZED FOR FOLLOW UP. COMPUTED TOMOGRAPHY NOTED IN-STENT RESTENOSIS IN THE IMPLANTED XIENCE XPEDITION STENT. ON (B)(6) 2017, BALLOON ANGIOPLASTY WAS PERFORMED AT THE TARGET LESION AND THE PATIENT CONDITION RESOLVED ON (B)(6) 2017. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Stenosis

    MAUDE report 7484940 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page